Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRybak-Wolf, Agnieszka-
dc.contributor.authorPlass, Mireya-
dc.description.abstractAlzheimer's disease (AD) is the most common age-related neurodegenerative disorder that heavily burdens healthcare systems worldwide. There is a significant requirement to understand the still unknown molecular mechanisms underlying AD. Current evidence shows that two of the major features of AD are transcriptome dysregulation and altered function of RNA binding proteins (RBPs), both of which lead to changes in the expression of different RNA species, including microRNAs (miRNAs), circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and messenger RNAs (mRNAs). In this review, we will conduct a comprehensive overview of how RNA dynamics are altered in AD and how this leads to the differential expression of both short and long RNA species. We will describe how RBP expression and function are altered in AD and how this impacts the expression of different RNA species. Furthermore, we will also show how changes in the abundance of specific RNA species are linked to the pathology of AD.-
dc.format.extent24 p.-
dc.publisherMDPI AG-
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofMolecules, 2021, vol. 26, num. 17, p. 5113-
dc.rightscc by (c) Rybak-Wolf, Agnieszka et al, 2021-
dc.subject.classificationMalaltia d'Alzheimer-
dc.subject.otherAlzheimer's disease-
dc.titleRNA Dynamics in Alzheimer’s Disease-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
molecules-26-05113.pdf1.24 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons